Clinical Alert
NIH stops one treatment arm of trial; other two treatments to continue.
The trial found that people with idiopathic pulmonary fibrosis (IPF) receiving a currently used triple-drug therapy consisting of prednisone, azathioprine, and N-acetylcysteine (NAC) had worse outcomes than those who received placebos or inactive substances.http://www.nlm.nih.gov/databases/alerts/2011_nhlbi_ifp.html
Find more information about this clinical trial at - http://clinicaltrials.gov/ct2/show/NCT00650091
